Hypointense transcerebral veins at T2*-weighted MRI: A marker of hemorrhagic transformation risk in patients treated by intravenous tissue plasminogen activator

被引：0
|
作者：
Nighoghossian, N
Hermier, M
Derex, L
Adeleine, P
Wiart, M
Berthezene, Y
Froment, JC
Honnorat, J
Phillipeau, F
Trouillas, P
机构：
[1] Hop Pierre Wertheimer, Lyon, France
[2] Creatis UMR 5515, Lyon, France
来源：
STROKE | 2004年 / 35卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：237 / 237
页数：1
相关论文
共 34 条
  • [1] Hypointense transcerebral veins at T2*-weighted MRI:: A marker of hemorrhagic transformation risk in patients treated with intravenous tissue plasminogen activator
    Hermier, M
    Nighoghossian, N
    Derex, L
    Adeleine, P
    Wiart, M
    Berthezène, Y
    Cotton, F
    Pialat, JB
    Dardel, P
    Honnorat, J
    Trouillas, P
    Froment, JC
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2003, 23 (11): : 1362 - 1370
  • [2] Brush Sign on 3-T T2*-Weighted MRI as a Potential Predictor of Hemorrhagic Transformation After Tissue Plasminogen Activator Therapy
    Terasawa, Yuka
    Yamamoto, Nobuaki
    Morigaki, Ryoma
    Fujita, Koji
    Izumi, Yuishin
    Satomi, Junichiro
    Harada, Masafumi
    Nagahiro, Shinji
    Kaji, Ryuji
    STROKE, 2014, 45 (01) : 274 - 276
  • [3] Clinical usefulness of the visibility of the transcerebral veins at 3T on T2*-weighted sequence in acute stroke patients
    Rosso, Charlotte
    Belleville, Martin
    Pires, Christine
    Dormont, Didier
    Crozier, Sophie
    Chiras, Jacques
    Samson, Yves
    Bonneville, Fabrice
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (06) : 1282 - 1287
  • [4] Clinical implication of hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator
    Bo-Lin Ho
    Chien-Fu Chen
    Ruey-Tay Lin
    Ching-Kuan Liu
    A-Ching Chao
    Neurological Sciences, 2016, 37 : 1799 - 1805
  • [5] Clinical implication of hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator
    Ho, Bo-Lin
    Chen, Chien-Fu
    Lin, Ruey-Tay
    Liu, Ching-Kuan
    Chao, A-Ching
    NEUROLOGICAL SCIENCES, 2016, 37 (11) : 1799 - 1805
  • [6] Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator
    Ribo, M
    Montaner, J
    Molina, CA
    Arenillas, JF
    Santamarina, E
    Quintana, M
    Alvarez-Sabín, J
    STROKE, 2004, 35 (09) : 2123 - 2127
  • [7] Immediate Hemorrhagic Transformation After Intravenous Tissue-Type Plasminogen Activator Injection in 2 Cocaine Users
    Baud, Maxime O.
    Brown, Ethan G.
    Singhal, Neel S.
    Hemphill, J. Claude
    STROKE, 2015, 46 (07) : e167 - e169
  • [8] Risk factors for early arterial reocclusion in patients treated with intravenous tissue plasminogen activator.
    Shaltoni, HM
    Wojner, AW
    Chen, CI
    Iguchi, Y
    Chernyshev, OY
    Garami, Z
    Campbell, MS
    Grotta, JC
    Alexandrov, AV
    STROKE, 2004, 35 (01) : 292 - 292
  • [9] The relationship between T2 white-matter hyperintensities and hemorrhagic transformation and neurological outcome after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke
    陈秀娣
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (03) : 188 - 189
  • [10] Location of the Susceptibility Vessel Sign on T2*-Weighted MRI and Early Recanalization within 1 Hour after Tissue Plasminogen Activator Administration
    Aoki, Junya
    Kimura, Kazunni
    Shibazaki, Kensaku
    Sakannoto, Yuki
    Saji, Naoki
    Uemura, Junichi
    CEREBROVASCULAR DISEASES EXTRA, 2013, 3 (01): : 111 - 120
1234